Skip to main content
. 2021 Aug 16;105(3):643–650. doi: 10.4269/ajtmh.20-1141

Table 4.

Patient Characteristics of patients with positive Trypanosoma cruzi serology divided by those with and without detectable T. cruzi by qPCR*

qPCR+ patients
(n = 16)
qPCR– patients
(n = 16)
P value
Female 10 (63%) 7 (44%) 0.288
Median age, years (IQR) 28 (22–42) 41.5 (30–53) 0.073
Hospitalized (vs. ambulatory) 6 (38%) 5 (31%) 0.710
Patients on ART for > 1 week 4 (25%) 11 (69%) 0.013
Fever 8/16 (50%) 6/16 (38%) 0.361
Weight loss 9/16 (56%) 5/16 (31%) 0.143
Headache 11/16 (69%) 5/16 (31%) 0.038
Mean body mass index (SD) 21.6 (19.1–26.6) 23.8 (22.0–26.0) 0.176
Median CD4+ count, cells/mm3 (IQR) 231 (29–393) 176.5 (86.5–505.5) 0.635
CD4+ < 100 cells/mm3 6/15 (40.0%) 4 (25%) 0.458
CD4+ < 200 cells/mm3 7/15 (47%) 8 (50%) 0.578
Median HIV VL, copies/mL (IQR) 7711 (2706–237,684) 3235 (53–169,815) 0.385§
Patients with HIV VL < 100 copies/mL 2/13 (15%) 3/11 (27%) 0.630§
Patients with HIV VL > 100,000 copies/mL 5/13 (38%) 3/11 (27%) 0.679§
ECG findings that could be attributed to Chagas disease 3 (19%) 2 (13%) 0.500§
Cardiomegaly on chest X-ray 3/14 (21%) 0/8 (0%) 0.273§
Mild or moderate cognitive deficits 4 (25%) 2 (13%) 0.365§
Reactivation 4 (20%) 0 (0%) 0.051§

ART = antiretroviral therapy; ECG = echocardiogram; IQR = interquartile range; qPCR = quantitative polymerase chain reaction; VL = viral load.

*

Positive qPCR includes those that were positive by either blood clot or whole blood.

Chi-square test.

Fisher’s exact test.

§

Mann-Whitney test.